Gilead Sciences

Biotech

Gilead Sciences (GILD) Stock Surges 4% on Positive Drug Trials and Promising Obesity and Weight Loss Treatments

Gilead Sciences (NASDAQ: GILD) witnessed a notable 4% surge in its stock price this morning, driven by a confluence of…

Read More »
Back to top button